Jobanputra N K, Jones R, Buckler G, Cody R P, Gochfeld M, Matte T M, Rich D Q, Rhoads G G
New Jersey Graduate Program in Public Health, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, Piscataway, USA.
Arch Pediatr Adolesc Med. 1998 Jun;152(6):548-53. doi: 10.1001/archpedi.152.6.548.
To assess the proficiency of commercial laboratories in analyzing lead in clinical blood samples from subjects without overt lead exposure.
We submitted masked duplicate blood lead specimens to 8 masked laboratories. Each laboratory received blood aliquots immediately following drawing (time 1) and 2 weeks later (time 2) from 7 human subjects and 3 bovine blood samples with known lead levels of 0.26, 0.57, and 0.79 micromol/L (5.4, 11.8, and 16.4 microg/dL). Of the 8 laboratories, 5 were commercial laboratories, 1 was a state laboratory, 1 was a research laboratory, and 1 was the Centers for Disease Control and Prevention reference laboratory.
Correlation coefficients were calculated, and differences within and between laboratories were assessed by analysis of variance.
Results were obtained for all specimens, with all the human subjects' overall mean lead levels being less than 0.48 micromol/L (<10 microg/dL). Each laboratory reported all human blood specimens appropriately, as having lead levels less than 0.48 micromol/L (<10 microg/dL) and within 0.14 micromol/L (3 microg/dL) of the overall mean for that subject. All internal reproducibilities were very high (range, 0.92-1.00) except for one (0.60), possibly lower because of 1 pair of specimens. Mean differences between blood samples analyzed at time 1 and time 2 ranged from -1.4 to 1.2, with only 2 laboratories having significant differences (P<.01).
Overall, there was strong reproducibility within and among laboratories, with no overall time trend or interlaboratory or intralaboratory variance. The storage conditions did not seem to affect the aggregate results. The data suggest that through implementation of the Centers for Disease Control and Prevention/Wisconsin Blood Lead Proficiency Testing Program, the Centers for Disease Control and Prevention's Blood Lead Laboratory Reference System, and mandated federal and state proficiency programs, laboratories in this geographic region have improved their performance as compared with previous published studies and an unpublished study.
评估商业实验室分析无明显铅暴露受试者临床血样中铅含量的熟练度。
我们向8个匿名实验室提交了匿名的重复血铅标本。每个实验室在采血后立即(时间1)和2周后(时间2)从7名人类受试者和3份已知铅含量分别为0.26、0.57和0.79微摩尔/升(5.4、11.8和16.4微克/分升)的牛血样本中接收血液等分试样。在这8个实验室中,5个是商业实验室,1个是州立实验室,1个是研究实验室,1个是疾病控制与预防中心参考实验室。
计算相关系数,并通过方差分析评估各实验室内部及实验室之间的差异。
所有标本均获得结果,所有人类受试者的总体平均铅含量均低于0.48微摩尔/升(<10微克/分升)。每个实验室都正确报告了所有人类血标本,其铅含量低于0.48微摩尔/升(<10微克/分升),且与该受试者的总体平均值相差在0.14微摩尔/升(3微克/分升)以内。除一个实验室(0.60)外,所有内部重复性都非常高(范围为0.92 - 1.00),可能是由于一对标本导致该实验室重复性较低。在时间1和时间2分析的血样之间的平均差异范围为 -1.4至1.2,只有2个实验室存在显著差异(P<0.01)。
总体而言,各实验室内部及之间具有很强的重复性,没有总体时间趋势或实验室间或实验室内差异。储存条件似乎并未影响总体结果。数据表明,通过实施疾病控制与预防中心/威斯康星州血铅熟练度测试计划、疾病控制与预防中心血铅实验室参考系统以及联邦和州规定的熟练度计划,与之前发表的研究和一项未发表的研究相比,该地理区域的实验室性能有所提高。